Profile
Ilse Roodink formerly worked at ImmunoPrecise Antibodies (Europe) BV, as Scientific Director and MindWalk Holdings Corp., as Chief Scientific Officer from 2021 to 2025.
Dr. Roodink received her undergraduate degree, graduate degree, and doctorate degree from Radboud University Nijmegen.
Former positions of Ilse Roodink
| Companies | Position | End |
|---|---|---|
| MINDWALK HOLDINGS CORP. | Chief Tech/Sci/R&D Officer | 2025-08-05 |
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in antibiotics | Chief Tech/Sci/R&D Officer | - |
Training of Ilse Roodink
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Radboud University Nijmegen
Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. BiotechnologyHealth Technology Operates as AI-driven biotherapeutic research and technology firm that develops & discovers antibodies | Health Technology |
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in antibiotics | Health Technology |
- Stock Market
- Insiders
- Ilse Roodink
















